Transforming ovarian cancer care by targeting minimal residual disease.
Publication
, Journal Article
Jazaeri, AA; Grisham, R; Knisely, A; Spranger, S; Zamarin, D; Hillman, RT; Lawson, BC; Burns, KH; Lee, S; Westin, SN; Moiso, E; Williams, MJ ...
Published in: Med
November 10, 2023
Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.
Duke Scholars
Published In
Med
DOI
EISSN
2666-6340
Publication Date
November 10, 2023
Volume
4
Issue
11
Start / End Page
755 / 760
Location
United States
Related Subject Headings
- Ovarian Neoplasms
- Neoplasm, Residual
- Humans
- Female
- Carcinoma, Ovarian Epithelial
Citation
APA
Chicago
ICMJE
MLA
NLM
Jazaeri, A. A., Grisham, R., Knisely, A., Spranger, S., Zamarin, D., Hillman, R. T., … Lu, K. H. (2023). Transforming ovarian cancer care by targeting minimal residual disease. Med, 4(11), 755–760. https://doi.org/10.1016/j.medj.2023.08.004
Jazaeri, Amir A., Rachel Grisham, Anne Knisely, Stefani Spranger, Dmitriy Zamarin, R Tyler Hillman, Barrett C. Lawson, et al. “Transforming ovarian cancer care by targeting minimal residual disease.” Med 4, no. 11 (November 10, 2023): 755–60. https://doi.org/10.1016/j.medj.2023.08.004.
Jazaeri AA, Grisham R, Knisely A, Spranger S, Zamarin D, Hillman RT, et al. Transforming ovarian cancer care by targeting minimal residual disease. Med. 2023 Nov 10;4(11):755–60.
Jazaeri, Amir A., et al. “Transforming ovarian cancer care by targeting minimal residual disease.” Med, vol. 4, no. 11, Nov. 2023, pp. 755–60. Pubmed, doi:10.1016/j.medj.2023.08.004.
Jazaeri AA, Grisham R, Knisely A, Spranger S, Zamarin D, Hillman RT, Lawson BC, Burns KH, Lee S, Westin SN, Moiso E, Williams MJ, Bardhan NM, Pisanic T, Matulonis U, Weigelt B, Shih I, Konstantinopoulos PA, Gaillard S, Wang L, Aghajanian C, D’Andrea AD, Hammond P, Shah S, Wucherpfennig KW, Lu KH. Transforming ovarian cancer care by targeting minimal residual disease. Med. 2023 Nov 10;4(11):755–760.
Published In
Med
DOI
EISSN
2666-6340
Publication Date
November 10, 2023
Volume
4
Issue
11
Start / End Page
755 / 760
Location
United States
Related Subject Headings
- Ovarian Neoplasms
- Neoplasm, Residual
- Humans
- Female
- Carcinoma, Ovarian Epithelial